Longeveron LLC (LGVN)

Longeveron LLC (LGVN) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $5.1M; returns 1 day +0.6%, 1 week +15.1%, 1 year -81.2%.

Longeveron Inc. (LGVN) is a clinical-stage regenerative medicine biotechnology company focused on developing cellular therapies for life-threatening, rare pediatric, and chronic aging-related conditions.

Groups LGVN belongs to

• Biotechnology
• Recent Reverse Splits
• Regenerative Medicine
• Clinical Stage Biotech
• Rare Diseases
• Alzheimer's Disease
• Life Sciences
• Biopharmaceutical
• Healthcare
• Aging Population Needs
• Fast Track Designation

LGVN financial model: income statement, cash flow and balance sheet